Search Results - "Kacimi, S E O"

Immunomodulatory effect of different statin regimens on regulatory T-cells among patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials by Greca, E, Kacimi, S E O, Ghozy, S, Wireko, A A, Toufik, A, Poudel, S, Prendi, B, Michel, G, Michel, J

“…Abstract Funding Acknowledgements Type of funding sources: None. Immunomodulatory effect of different statin regimens on regulatory T-cells  among patients…”
Get full text

OS12.7.A INTEGRATED DIGITAL PATHOLOGY AND TRANSCRIPTOMIC ANALYSIS OF ADULT GLIOMAS WITH HIGH LYMPHOCYTE INFILTRATION IDENTIFIES CELLULAR AND SPATIAL DETERMINANTS OF IMMUNE INFILTRATION WITH PROGNOSTIC VALUE by Salhi, L, Lerond, J, Nadaradjane, A A, Drouiche, L, Otero Pizarro, M M, Hanna Doumit Sakr, L, Labreche, K, Kacimi, S E O, Bellamy, C, Picca, A, Stimmer, L, Brocic, J, Letourneur, Q, Barka, B, Carpentier, C, Marie, Y, Madry, H, Bhalshankar, J, Nicolle, R, Malaizé, H, Mathon, B, Mokhtari, K, Idbaih, A, Hoang-Xuan, K, Sanson, M, Alentorn, A, Duval, A, Le Rouzic, P, Dieu-Nosjean, M, Bloch, I, Touat, M, Bielle, F

“…Abstract BACKGROUND Adult glioma patients rarely benefit from immunotherapy. This lack of efficacy has been related to gliomas immune “cold” microenvironment,…”
Get full text

KS02.5.A OVERALL SURVIVAL ASSOCIATED WITH FIRST-LINE PCV OR TEMOZOLOMIDE IN COMBINATION WITH RADIOTHERAPY IN PATIENTS WITH IDH-MUTANT, 1P/19Q CODELETED, GRADE 3 OLIGODENDROGLIOMA: ANALYSIS FROM THE POLA COHORT by Kacimi, S E O, Dehais, C, Carpentier, C, Chinot, O, Bronnimann, C, Vauleon, E, Djelad, A, Moyal, E C, Campone, M, Ducloie, M, Noel, G, Cuzzubbo, S, Thaillandier, L, Ramirez, C, Colin, C, Appay, R, Tabouret, E, Nichelli, L, Mathon, B, Thomas, A, Tran, S, Bielle, F, Alentor, A, Labreche, K, Idbaih, A, Figarella-Branger, D, Ducray, F, Touat, M

“…Abstract BACKGROUND Patients with IDH-mutant, 1p/19q codeleted, grade 3 oligodendroglioma (Olig-3) derive benefit from the addition of alkylating agent…”
Get full text